HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

6- (N- (4- aminobutyl)- N- ethyl)amino- 2,3- dihydrophthalazine- 1,4- dione (ABEI)

forms a conjugate with progesterone; conjugate used for immunoassay of plasma progesterone
Also Known As:
ABEI; N-(aminobutyl)-N-(ethylisoluminol); aminobutylethylisoluminol; 1,4-Phthalazinedione, 6-((4-aminobutyl)ethylamino)-2,3-dihydro-
Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Cui, Hua: 4 articles (01/2020 - 09/2011)
2. Shen, Wen: 3 articles (01/2020 - 09/2011)
3. Bian, Zhiping: 2 articles (10/2019 - 09/2011)
4. Yang, Di: 2 articles (10/2019 - 09/2011)
5. Chai, Yaqin: 2 articles (01/2019 - 08/2017)
6. Yuan, Ruo: 2 articles (01/2019 - 08/2017)
7. Haghighatbin, Mohammad A: 1 article (01/2020)
8. Mi, Lan: 1 article (01/2020)
9. Wang, Jue: 1 article (01/2020)
10. Li, Fang: 1 article (10/2019)

Related Diseases

1. Myocardial Infarction
01/01/2020 - "Using Hg2+ as the ECL signal moderator based on specific interactions between Hg2+ and thymine-thymine pairs, conjoined with the synthesized g-C3N4/ABEI/Hg2+ nanohybrids with outstanding PRECL properties as the sensing interface, a label-free and all-in-one ratiometric ECL bioassay combined with a rolling circle amplification (RCA) strategy was designed for the detection of miR-133a as a biomarker in early diagnosis of acute myocardial infarction (AMI). "
01/01/2018 - "Furthermore, a coreactant-free and label-free ECL immunosensor has been established for the determination of early acute myocardial infarction biomarker copeptin based on luminescent immuno-gold nanoassemblys consisting of Cu2+-Cys-ABEI-GNPs-CS and immuno-gold nanoparticles prepared by connecting copeptin antibody with trisodium citrate stabilized gold nanoparticles. "
09/15/2011 - "A novel nanoparticle-based electrochemiluminescence (ECL) immunosensor was designed for highly sensitive and selective detection of human cardiac troponin I (cTnI), an important Acute Myocardial Infarction (AMI)-related biomarker, by using N-(aminobutyl)-N-(ethylisoluminol)-functionalized gold nanoparticles (ABEI-AuNPs) as labels. "
10/15/2019 - "Chemiluminescence (CL) immunoassays for simultaneous detection of early acute myocardial infarction (AMI) biomarkers, including copeptin, heart-type fatty acid binding protein (h-FABP), and cardiac troponin I (cTnI), were developed by using Co2+/N-(aminobutyl)-N-(ethylisoluminol) (ABEI) functionalized magnetic carbon composite (Co2+-ABEI-Fe3O4@void@C) as an interface and a three-dimensional microfluidic paper-based device (3D μPAD) as a detection system. "
2. Neoplasms (Cancer)
3. Necrosis

Related Drugs and Biologics

1. 6- (N- (4- aminobutyl)- N- ethyl)amino- 2,3- dihydrophthalazine- 1,4- dione (ABEI)
2. Biomarkers (Surrogate Marker)
3. Troponin I
4. Gold
5. Fatty Acid-Binding Proteins
6. Thymine
7. Silver
8. Indicators and Reagents (Reagents)
9. Carbon
10. Fatty Acid Binding Protein 3